Data / Drug companies / PLD Acquisitions LLC DBA Avma Pharma Solutions
PLD Acquisitions LLC DBA Avma Pharma Solutions: 27 products in the FDA NDC directory, labeler code 63548
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
PLD Acquisitions LLC DBA Avma Pharma Solutions (labeler code 63548) lists 27 products in the FDA National Drug Code Directory, covering 7 finished drugs by generic name. By type: 14 over the counter drugs, 11 bulk ingredients. Its main marketing category is generic drugs (ANDA). The newest product started marketing on April 30, 2025.
The request: Watch PLD Acquisitions LLC DBA Avma Pharma Solutions (FDA labeler code 63548): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 63548
- Products in commercial distribution
- 27
- Packages
- 48
- Finished drugs by generic name
- 7
- Prescription products
- 2
- Over the counter products
- 14
- Flagged as original packager
- 13 of 13 products that carry the flag
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- August 1, 2013
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 15 | 55.6% |
| Bulk ingredients for compounding | 11 | 40.7% |
| Drugs for further processing | 1 | 3.7% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 14 | 51.9% |
| Bulk ingredients | 11 | 40.7% |
| Prescription drugs | 2 | 7.4% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Omeprazole | 4 | 106 |
| Fexofenadine hcl | 3 | 39 |
| Ibuprofen | 2 | 190 |
| Zolmitriptan | 2 | 22 |
| Nicotine polacrilex | 2 | 57 |
| Loratadine | 1 | 125 |
| Ibuprofen, diphenhydramine citrate | 1 | 1 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, delayed release | 8 | 29.6% |
| Tablet | 6 | 22.2% |
| Tablet, coated | 4 | 14.8% |
| Tablet, film coated | 4 | 14.8% |
| Lozenge | 2 | 7.4% |
| Solution | 2 | 7.4% |
| Capsule | 1 | 3.7% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
| Class | Products |
|---|---|
| Histamine-1 Receptor Antagonist | 4 |
| Proton Pump Inhibitor | 4 |
| Nonsteroidal Anti-inflammatory Drug | 3 |
| Serotonin-1b and Serotonin-1d Receptor Agonist | 2 |
| Cholinergic Nicotinic Agonist | 2 |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Prilosec omeprazole | 63548-9731 | Tablet, delayed release | Bulk ingredients for compounding | April 30, 2025 |
| Prilosec omeprazole | 63548-9721 | Tablet, delayed release | Bulk ingredients for compounding | April 30, 2025 |
| Omeprazole magnesium | 63548-7371 | Tablet, delayed release | Bulk ingredients for compounding | April 30, 2025 |
| Omeprazole | 63548-2971 | Tablet, delayed release | Bulk ingredients for compounding | April 30, 2025 |
| Calcium acetate | 63548-6990 | Capsule | Bulk ingredients for compounding | March 15, 2025 |
| Prednisolone sodium phosphate | 63548-5320 | Solution | Bulk ingredients for compounding | March 15, 2025 |
| Prednisolone sodium phosphate | 63548-5300 | Solution | Bulk ingredients for compounding | March 15, 2025 |
| Loratadine | 63548-9150 | Tablet | Bulk ingredients for compounding | November 20, 2024 |
| Ibuprofen diphenhydramine citrate | 63548-1970 | Tablet, coated | Bulk ingredients for compounding | November 20, 2024 |
| Zolmitriptan | 63548-1020 | Tablet, film coated | Bulk ingredients for compounding | November 20, 2024 |
| Zolmitriptan | 63548-1010 | Tablet, film coated | Bulk ingredients for compounding | November 20, 2024 |
| Omeprazole | 63548-8040 | Tablet, delayed release | Generic drugs (ANDA) | October 31, 2024 |
| Omeprazole | 63548-7370 | Tablet, delayed release | Generic drugs (ANDA) | October 31, 2024 |
| Omeprazole | 63548-4080 | Tablet, delayed release | Generic drugs (ANDA) | October 31, 2024 |
| Omeprazole | 63548-2970 | Tablet, delayed release | Generic drugs (ANDA) | October 31, 2024 |
| Ibuprofen 200 mg and Diphenhydramine Citrate 38 mg | 63548-0197 | Tablet | Generic drugs (ANDA) | April 11, 2024 |
| Aspirin | 63548-0867 | Tablet | Drugs for further processing | February 28, 2020 |
| Allergy Relief | 63548-0664 | Tablet | Generic drugs (ANDA) | October 1, 2019 |
| Allergy Relief | 63548-0663 | Tablet, coated | Generic drugs (ANDA) | October 1, 2019 |
| Childrens Allergy Relief | 63548-0662 | Tablet | Generic drugs (ANDA) | October 1, 2019 |
| Nicotine Mini | 63548-0264 | Lozenge | Generic drugs (ANDA) | April 1, 2019 |
| Nicotine Mini | 63548-0262 | Lozenge | Generic drugs (ANDA) | April 1, 2019 |
| Loratadine | 63548-0753 | Tablet | Generic drugs (ANDA) | October 30, 2018 |
| Zolmitriptan | 63548-0102 | Tablet, film coated | Generic drugs (ANDA) | February 27, 2017 |
| Zolmitriptan | 63548-0101 | Tablet, film coated | Generic drugs (ANDA) | February 27, 2017 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.